TotalMarketCap

Bluejay Diagnostics

BJDXNasdaq United StatesHealth CareMedical/Dental Instruments

Market cap

$2.441 M

$2.19 -4.58%

Close of 6 Nov 2026

As of 6 Nov 2026, Bluejay Diagnostics (BJDX) has a market capitalization of $2.44M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$6.85M

Loss-making

Shares outstanding

4,468,051

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medical/Dental Instruments, ranked by market cap

All 124 →
  1. #115Vivos TherapeuticsVVOS$3.44M
  2. #116Autonomix MedicalAMIX$3.08M
  3. #117Bluejay DiagnosticsBJDX$2.44M
  4. #118Co-DiagnosticsCODX$2.41M
  5. #119IceCure MedicalICCM$2.35M

What if Bluejay Diagnostics were worth as much as…

Open the what-if tool →

Gold $28.2T

$25,278,917

Per share 11,569,298× higher

Bitcoin $1.53T

$1,367,798

Per share 625,995× higher

Apple $5.02T

$4,490,354

Per share 2,055,082× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Bluejay Diagnostics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.